In addition, Fanconi anemia patients with biallelic mutations in BRCA1, BRCA2 and PALB2 show an increased risk of hematological malignancies and solid tumors [26,27,28,29,30,31,32,33]. The gene discussed is BRCA2; the disease is Fanconi anemia.